Changes after publication
March 2014: implementation section updated to clarify that thrombolytic drugs are recommended as an option for treating acute myocardial infarction. Additional minor maintenance update also carried out.
March 2012: minor maintenance
In January 2006, following consultation, the Institute decided to make this guidance 'static.' This means that the guidance remains in force and has no scheduled review date. See the review decision, under 'Background information', for further details.